With unchallenged experience in bispecific antibody production, Creative Biolabs offers custom BsAbs for diverse scientific and clinical researches in ophthalmology. We integrate various technology platforms in order to provide high quality BsAbs with first class controllability and operability.
In the field of ophthalmology, most ophthalmic diseases occur due to angiogenesis or vasculogenesis, including wet age-related macular degeneration (wet-AMD), geographic atropy (GA) (dry advanced form), diabetic macular edema, macular edema following Central Retinal Vein Occlusion (CRVO), macular edema following Retinal Vein Occlusion (RVO), Diabetic retinopathy, myopic choroidal neovascularization (myopic CNV), etc. Therefore, factors related to angiogenesis/vasculogenesis are potential targets in immunotherapy of ophthalmic diseases. Among these potential antigens, VEGFA and angiopoietins are the most promising ones. Creative Biolabs can develop the most suitable BsAbs of different formats targeting these specific antigens.
Creative Biolabs has successfully provided BsAb services for diverse clients with specific requirements.
For research use only. Not intended for any clinical use.